Murphy & Mullick Capital Management Corp Acquires Shares of 1,125 Option Care Health, Inc. (NASDAQ:OPCH)

Murphy & Mullick Capital Management Corp bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,125 shares of the company’s stock, valued at approximately $26,000.

A number of other large investors have also recently modified their holdings of the business. FMR LLC increased its position in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after purchasing an additional 4,304,896 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after buying an additional 1,328,326 shares in the last quarter. Victory Capital Management Inc. lifted its stake in shares of Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock valued at $49,310,000 after acquiring an additional 503,840 shares during the last quarter. Magnetar Financial LLC boosted its holdings in shares of Option Care Health by 23.1% during the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company’s stock valued at $54,534,000 after acquiring an additional 441,265 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new stake in Option Care Health during the 4th quarter worth $6,932,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Down 1.3 %

Shares of Option Care Health stock opened at $34.73 on Friday. The firm has a market cap of $5.70 billion, a price-to-earnings ratio of 29.18, a PEG ratio of 2.30 and a beta of 1.33. The stock’s 50-day moving average is $32.47 and its 200 day moving average is $28.44. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Analyst Ratings Changes

Several research firms recently commented on OPCH. JPMorgan Chase & Co. lifted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research upped their price target on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Finally, Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.